Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $18,661 - $21,752
-253 Reduced 8.29%
2,799 $228,000
Q4 2022

Feb 13, 2023

BUY
$80.67 - $352.29 $184,734 - $806,744
2,290 Added 300.52%
3,052 $252,000
Q2 2022

Aug 10, 2022

BUY
$322.67 - $449.65 $245,874 - $342,633
762 New
762 $264,000
Q3 2021

Nov 15, 2021

SELL
$444.87 - $538.88 $474,231 - $574,446
-1,066 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$387.35 - $450.26 $65,074 - $75,643
168 Added 18.71%
1,066 $480,000
Q1 2021

May 17, 2021

BUY
$314.62 - $411.0 $282,528 - $369,078
898 New
898 $343,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.94B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Spouting Rock Asset Management, LLC Portfolio

Follow Spouting Rock Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spouting Rock Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spouting Rock Asset Management, LLC with notifications on news.